Navigation Links
Novel Xeloda(R) Dosing Schedule May Offer Well-Tolerated Alternative for Treatment of Advanced Breast Cancer
Date:4/18/2008

fication or interruption.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by Med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a Top Company for Older Workers (AARP) and one of the Best Companies to Work For in America (Fortune). For additional information about the U.S. pharmaceuticals business, visit our Web site http://www.rocheusa.com. Product and treatment information for U.S. healthcare professionals is available at http://www.RocheExchange.com.

All trademarks used or mentioned in this release are protected by law.

Contacts: Ginny Valenze

Roche

Office: 973-562-2783

virginia.valenze@roche.com

Daphne Hoytt

Manning Selvage & Lee

Office: 212-468-3558

Cell: 917-406-2779

daphne.hoytt@mslpr.com


'/>"/>
SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novel Technology Breaks Through Cancer Pain
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
4. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... N.J. , July 6, 2015 ... on developing novel therapeutics that target inflammation and ... Bradford , M.D., PhD, as Chief Medical Officer. ... company,s clinical development strategy and programs, which include ... other inflammatory and fibrotic conditions.  Bill is an ...
(Date:7/6/2015)... July 6, 2015   Cepheid (Nasdaq: CPHD ... for its 2015 second quarter ended June 30, 2015 ... the market. The Company will host a ... July 23, 2015, to discuss the results.  To access ... http://ir.cepheid.com at least 15 minutes before the scheduled ...
(Date:7/6/2015)... 2015 China Information Technology, Inc. (the "Company" ... integrated cloud-based platform, exchange, and big data solutions in ... Company launched its mobile app for Healthcare One Pass, ... on mobile devices. The Company jointly hosted the launch ... Bureau and Shenzhen News Net.   The mobile ...
Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4
(Date:7/6/2015)... ... July 06, 2015 , ... Seedstock today announced Pierre Sleiman, founder and CEO ... Annual Seedstock Sustainable Agriculture Conference – “Innovation and the Small Farmer” – to be ... University of California-San Diego, will explore solutions and methodologies that small farmers and entrepreneurs ...
(Date:7/6/2015)... ... 06, 2015 , ... In a split second, breaking a bone can cause ... having a fracture through the bone health screenings conducted by American Bone Health trained ... because our residents need this information to remain independent and strong for many more ...
(Date:7/6/2015)... ... ... Dr. Lawrence Green is now offering the newly FDA-approved Kybella injectable to ... method to dissolve fat cells and is the first of its kind to be ... commonly known as a double chin. Dr. Green participated in clinical trials for Kybella ...
(Date:7/6/2015)... ... July 06, 2015 , ... Thanks to donations and ... Hospice received the Music & Memory Certification for hospice patients and adult day center ... music not only to patients but also to their families and volunteers. Music & ...
(Date:7/5/2015)... ... July 05, 2015 , ... Women's Excellence in ... in Lake Orion. These classes are geared towards families that want their children ... break. , The fitness class will take place TUESDAYS at 4:30pm. Questions? ...
Breaking Medicine News(10 mins):Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:National Bone Health Screening and Awareness Day 2Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4
... are risk factors for developing some types of cancer, according ... Korean patients for 10 years and tracked new cancer // ... with diabetes and those without diabetes but with higher fasting ... die from cancer. The group with the highest fasting blood ...
... appears to help people avoid seizures caused by a ... with the antiparasitic drug albendazole which they thought might ... experience. They randomized 120 patients with signs of the ... milligrams of albendazole per day and 6 milligrams of ...
... reduce the mortality rate and number of exacerbations COPD ... researchers from the University of Washington show otherwise. ... were prescribed inhaled corticosteroids for at least 80 percent ... never used inhaled corticosteroids served as the comparing group. ...
... could help people quit smoking. Laser therapy also does not ... to acupuncture points // on the body and ear to ... , has no side effects and smokers need only three ... ,Researchers studied 340 smokers who either received three treatments, four ...
... new discovery reveals a new cause of thyroid cancer. Researchers ... three genetic changes // happen. The genes affected include ... to radiation, the changes generally happen with the BRAF gene. ... changes occur in the RET gene. In both cases, the ...
... and Prevention, there are between 800,000 and 900,000 people ... and destroys T-cells in the immune system. ,Previous ... be infected with HIV, and a new study helps ... human foreskin. They found each sample contained cells expressing ...
Cached Medicine News:
... MBA is a complete practice and ... for optometrists, opticians and ophthalmologists- It ... users seeking a graphically rich and ... complement of solid features and functionality- ...
... 120 hematology system is ... workflow and achieve long-term ... offers a unique portfolio ... the needs of clinicians, ...
The Advia 60 is designed to deliver powerful performance in a small package....
The SF-3000 automated hematology analyzer can provide accurate and precise 23-parameter hematolgy results including a fully automated WBC 5-part differential from a compact space-save design....
Medicine Products: